BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18982820)

  • 1. Is asymptomatic peripheral neuropathy present in Nigerian diabetic patients? An assessment using the United Kingdom screening test (UKST) and bio-thesiometry.
    Oguejiofor OC; Oli JM; Ajaero CN; Odenigbo CU; Odike MA
    Afr J Med Med Sci; 2008 Sep; 37(3):265-71. PubMed ID: 18982820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are the symptoms of diabetic peripheral neuropathy in Nigerian patients objective? An evaluation using the United Kingdom Screening Test (UKST) and Bio-Thesiometry.
    Oguejiofor OC; Oli JM; Ajaero CN; Odenigbo CU; Odike MA
    Niger J Clin Pract; 2009 Jun; 12(2):113-9. PubMed ID: 19764655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.
    Oguejiofor OC; Odenigbo CU; Oguejiofor CB
    Niger J Clin Pract; 2010 Sep; 13(3):240-7. PubMed ID: 20857777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice.
    Kamenov ZA; Petrova JJ; Christov VG
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):226-33. PubMed ID: 20200815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Foot disease in Icelandic patients with established type 2 diabetes].
    Heimisdottir F; Gudnason V; Sigurdsson G; Benediktsson R
    Laeknabladid; 2008 Feb; 94(2):109-14. PubMed ID: 18310775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy.
    Moghtaderi A; Bakhshipour A; Rashidi H
    Clin Neurol Neurosurg; 2006 Jul; 108(5):477-81. PubMed ID: 16150538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of vibratory threshold in the diagnosis of diabetic neuropathy].
    Ribera RL; Valls J; González-Clemente JM; Vidal J; Manzanares JM; Esmatjes E
    Rev Clin Esp; 1994 Oct; 194(10):901-5. PubMed ID: 7800871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between asymptomatic median mononeuropathy and diabetic polyneuropathy severity in patients with diabetes mellitus.
    Stamboulis E; Voumvourakis K; Andrikopoulou A; Koutsis G; Tentolouris N; Kodounis A; Tsivgoulis G
    J Neurol Sci; 2009 Mar; 278(1-2):41-3. PubMed ID: 19059612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of vibratory perception thresholds in patients with diabetic neuropathy.
    Bertelsmann FW; Heimans JJ; van Rooy JC; Heine RJ; van der Veen EA
    Diabetes Res; 1986 Nov; 3(9):463-6. PubMed ID: 3829585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
    Kamei N; Yamane K; Nakanishi S; Yamashita Y; Tamura T; Ohshita K; Watanabe H; Fujikawa R; Okubo M; Kohno N
    J Diabetes Complications; 2005; 19(1):47-53. PubMed ID: 15642490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of sensory neuropathy in diabetic patients without diabetic foot problems.
    Nather A; Neo SH; Chionh SB; Liew SC; Sim EY; Chew JL
    J Diabetes Complications; 2008; 22(2):126-31. PubMed ID: 18280443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-invasive diagnosis of angiopathies and neuropathies in screening for the diabetic foot syndrome].
    Jirkovská A; Wosková V; Bartos V; Skibová J
    Vnitr Lek; 1998 May; 44(5):269-73. PubMed ID: 9820070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of symptoms of sensorimotor and autonomic neuropathy in Type 1 and Type 2 diabetic subjects.
    Kästenbauer T; Irsigler P; Sauseng S; Grimm A; Prager R
    J Diabetes Complications; 2004; 18(1):27-31. PubMed ID: 15019596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of the Diabetic Neuropathy Score and Diabetic Neuropathy Examination score as screening tools for the detection of distal symmetrical diabetic neuropathy.
    Liyanage PL; Lekamwasam S; Weerarathna TP
    J Diabetes; 2012 Sep; 4(3):264-5. PubMed ID: 22507170
    [No Abstract]   [Full Text] [Related]  

  • 15. Pupillography refines the diagnosis of diabetic autonomic neuropathy.
    Dütsch M; Marthol H; Michelson G; Neundörfer B; Hilz MJ
    J Neurol Sci; 2004 Jul; 222(1-2):75-81. PubMed ID: 15240199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds.
    Coppini DV; Wellmer A; Weng C; Young PJ; Anand P; Sönksen PH
    J Clin Neurosci; 2001 Nov; 8(6):520-4. PubMed ID: 11683597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative measurement of cutaneous perception in diabetic neuropathy.
    Vinik AI; Suwanwalaikorn S; Stansberry KB; Holland MT; McNitt PM; Colen LE
    Muscle Nerve; 1995 Jun; 18(6):574-84. PubMed ID: 7753119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients.
    Lozeron P; Nahum L; Lacroix C; Ropert A; Guglielmi JM; Said G
    J Neurol; 2002 May; 249(5):569-75. PubMed ID: 12021947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for peripheral neuropathy: which tools?].
    Gin H; Rigalleau V
    Diabetes Metab; 2002 Jun; 28(3):250-4. PubMed ID: 12149608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidden dangers revealed by misdiagnosed diabetic neuropathy: A comparison of simple clinical tests for the screening of vibration perception threshold at primary care level.
    Azzopardi K; Gatt A; Chockalingam N; Formosa C
    Prim Care Diabetes; 2018 Apr; 12(2):111-115. PubMed ID: 29029862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.